- Home
- CBUS vs BYSI Comparison
CBUS vs BYSI Comparison
Compare CBUS & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- BYSI
- Stock Information
- Founded
- CBUS 2010
- BYSI 2010
- Country
- CBUS United States
- BYSI United States
- Employees
- CBUS N/A
- BYSI N/A
- Industry
- CBUS Agricultural Chemicals
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- CBUS Industrials
- BYSI Health Care
- Exchange
- CBUS Nasdaq
- BYSI Nasdaq
- Market Cap
- CBUS 65.3M
- BYSI 71.0M
- IPO Year
- CBUS 2017
- BYSI 2017
- Fundamental
- Price
- CBUS $1.50
- BYSI $3.15
- Analyst Decision
- CBUS Strong Buy
- BYSI
- Analyst Count
- CBUS 3
- BYSI 0
- Target Price
- CBUS $22.00
- BYSI N/A
- AVG Volume (30 Days)
- CBUS 709.5K
- BYSI 140.7K
- Earning Date
- CBUS 08-07-2025
- BYSI 08-11-2025
- Dividend Yield
- CBUS N/A
- BYSI N/A
- EPS Growth
- CBUS N/A
- BYSI N/A
- EPS
- CBUS N/A
- BYSI N/A
- Revenue
- CBUS $4,751,000.00
- BYSI N/A
- Revenue This Year
- CBUS $32.97
- BYSI N/A
- Revenue Next Year
- CBUS $66.40
- BYSI N/A
- P/E Ratio
- CBUS N/A
- BYSI N/A
- Revenue Growth
- CBUS 104.78
- BYSI N/A
- 52 Week Low
- CBUS $1.40
- BYSI $0.98
- 52 Week High
- CBUS $10.77
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- CBUS 37.01
- BYSI 72.10
- Support Level
- CBUS $1.40
- BYSI $2.73
- Resistance Level
- CBUS $1.58
- BYSI $3.44
- Average True Range (ATR)
- CBUS 0.22
- BYSI 0.33
- MACD
- CBUS -0.09
- BYSI 0.12
- Stochastic Oscillator
- CBUS 5.43
- BYSI 81.49
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.